5-73894487-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001177693.2(ARHGEF28):c.3753C>T(p.Asp1251Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0201 in 1,613,868 control chromosomes in the GnomAD database, including 1,218 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.020 ( 114 hom., cov: 33)
Exomes 𝑓: 0.020 ( 1104 hom. )
Consequence
ARHGEF28
NM_001177693.2 synonymous
NM_001177693.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.231
Genes affected
ARHGEF28 (HGNC:30322): (Rho guanine nucleotide exchange factor 28) This gene encodes a member of the Rho guanine nucleotide exchange factor family. The encoded protein interacts with low molecular weight neurofilament mRNA and may be involved in the formation of amyotrophic lateral sclerosis neurofilament aggregates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 5-73894487-C-T is Benign according to our data. Variant chr5-73894487-C-T is described in ClinVar as [Benign]. Clinvar id is 257369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-73894487-C-T is described in Lovd as [Likely_benign]. Variant chr5-73894487-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.231 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0925 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF28 | NM_001177693.2 | c.3753C>T | p.Asp1251Asp | synonymous_variant | 29/36 | ENST00000513042.7 | NP_001171164.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF28 | ENST00000513042.7 | c.3753C>T | p.Asp1251Asp | synonymous_variant | 29/36 | 5 | NM_001177693.2 | ENSP00000441436.1 |
Frequencies
GnomAD3 genomes AF: 0.0198 AC: 3018AN: 152148Hom.: 112 Cov.: 33
GnomAD3 genomes
AF:
AC:
3018
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0384 AC: 9554AN: 248892Hom.: 776 AF XY: 0.0326 AC XY: 4406AN XY: 135040
GnomAD3 exomes
AF:
AC:
9554
AN:
248892
Hom.:
AF XY:
AC XY:
4406
AN XY:
135040
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0202 AC: 29485AN: 1461602Hom.: 1104 Cov.: 31 AF XY: 0.0195 AC XY: 14147AN XY: 727074
GnomAD4 exome
AF:
AC:
29485
AN:
1461602
Hom.:
Cov.:
31
AF XY:
AC XY:
14147
AN XY:
727074
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0199 AC: 3029AN: 152266Hom.: 114 Cov.: 33 AF XY: 0.0201 AC XY: 1498AN XY: 74454
GnomAD4 genome
AF:
AC:
3029
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
1498
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
66
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at